表紙
市場調査レポート

インドの神経精神医学 (医薬品・装置) 市場動向・機会・予測 2015-2020年

India Neuropsychiatry (Drugs and Devices) Market: Trends, Opportunities and Forecasts 2015-2020

発行 Azoth Analytics 商品コード 347584
出版日 ページ情報 英文 114 Pages
即納可能
価格
本日の銀行送金レート: 1USD=104.18円で換算しております。
Back to Top
インドの神経精神医学 (医薬品・装置) 市場動向・機会・予測 2015-2020年 India Neuropsychiatry (Drugs and Devices) Market: Trends, Opportunities and Forecasts 2015-2020
出版日: 2015年12月23日 ページ情報: 英文 114 Pages
概要

インドの神経精神医学市場は、2015年から2020年にかけて9.12%のCAGRを示すと予測されています。

当レポートでは、インドの神経精神医学市場について調査し、製品概要、市場の促進因子・課題・動向、神経精神医学医薬品市場の規模と予測、神経精神医学装置市場の規模と予測、および主要企業のプロファイルなどをまとめています。

第1章 調査手法

第2章 製品概要

第3章 エグゼクティブサマリー

第4章 インドの経済プロファイル

第5章 製品概要

第6章 インドにおける神経精神医学の産業構造

第7章 インドにおける神経精神医学の展望

第8章 インドにおける神経精神医学市場の展望

  • 治療装置市場規模・予測
    • 金額ベース
    • 金額ベースの予測
    • 医薬品、金額、パーセンテージ別
    • 医薬品、金額、パーセンテージ別の予測
  • 総装置市場規模・予測
    • 金額ベース
    • 金額ベースの予測
    • 地域別
    • 地域別の予測
  • 治療装置市場規模・予測
    • 金額ベース
    • 金額ベースの予測
  • 治療装置市場規模・予測
    • 金額ベース
    • 金額ベースの予測
  • 医薬品市場規模・予測
    • 金額ベース
    • 金額ベースの予測
    • 地域別
    • 地域別の予測

第9章 インドの神経精神医学市場:政策・規制環境

第10章 インドの神経精神医学市場:ダイナミクス

第11章 インドの神経精神医学産業:動向・発展

第12章 インドの経済プロファイル

第13章 神経精神医学産業のSWOT分析

第14章 外国企業にとっての市場参入戦略

第15章 インドにおける神経精神医学医薬品市場の分析:主要医薬品メーカー別

第16章 競合情勢

第17章 企業プロファイル

  • Sun Pharmaceutical Industries Ltd.
  • Torrent Pharma
  • GlaxoSmithKline Pharmaceuticals Ltd.
  • Cipla
  • Abbott Limited
  • Biocon Limited
  • Glenmark Pharmaceuticals
  • Alembic Ltd.
  • Nicholas Primal
  • Aventis Pharma Limited

第18章 戦略的提言

図表リスト

目次

Executive Summary

The Indian neuropsychiatry market is driven by the consumer awareness of health care resulting in access for early treatment along with increasing cases of mental disorders.

Indian Neuropsychiatry Market is a growing market with key players holding dominant positions. The report is classified on the basis of drugs market as well as the devices market. Indian Neuropsychiatry Drugs Market has been growing at an average pace over the last five years on account of rising healthcare expenditure, increasing diagnostic cases of epilepsy and other divisions of neurology. During 2015-20, Indian Neuropsychiatry Drugs Market is anticipated to grow at an increased rate on account of higher cases of Alzheimer patients especially in India. Moreover, consumers are increasingly becoming aware of the healthcare leading to large number of neurology treatments being performed.

The neuropsychiatry devices market is still on the growing path at a CAGR of 9.16% valued at xx million USD by 2020 from xx million USD in 2015 where both domestic and international players are having strong presence in diagnostic and treatment devices, considering more number of patients are being diagnosed using the devices. Also, when the patients are unresponsive to the medicinal drugs, treatment devices are used as a next step of measurement. Due to the fast paced lifestyle of population, increasing number of patients are suffering from neurological disorders and are opting for early treatment, thereby, driving the neuropsychiatric market in India.

According to Azoth Analytics research report, “Indian Neuropsychiatry Market (2015-2020F)” Indian Neuropsychiatry Market is projected to exhibit a CAGR of 9.12% during 2015 - 2020. Few of the leading companies operating in neuropsychiatric drug market in India include Sun Pharma, Intas, Torrent, Sanofi & Abbott whereas companies in devices market in India include RMS India, Nihon Kohden etc.

Scope of the Report

“India Neuropsychiatry (Drugs and Devices) Market: Trends, Opportunities and Forecasts (2015-2020F) - (Segmentation By Value and Volume, By Region, Diagnosis and Treatment Devices, Value Chain, Key Players, Regulatory Perspective, Margins and Revenue Contribution) analyses” the following aspects of Indian Neuropsychiatry Drugs and Devices Market:

  • Product Overview (Top Companies Market).
  • Market, Drivers & Challenges and Trends.
  • Indian Neuropsychiatry Drugs Market, Size & Forecast.
  • Indian Neuropsychiatry Devices Market, Size & Forecast.

Why You Should Buy This Report?

  • To gain an in-depth understanding of Indian neuropsychiatry market
  • To identify the on-going trends and anticipated growth in the next five years
  • To help industry consultants, neuropsychiatric drugs and devices manufacturers, suppliers and distributors align their market-centric strategies
  • To gain insights on the prevalent market entry strategies in neuropsychiatric market for domestic as well as foreign companies
  • To obtain research based business decision and add weight to presentations and marketing material
  • To gain competitive knowledge of leading players
  • To avail limited customization in the report without any extra charges and get research data or trends added in the report as per the buyer's specific needs

Table of Contents

1. Research Methodology

2. Product Overview

3. Executive Summary

4. India Economic Profile

5. Product Overview

6. India Neuropsychiatry Industry Structure

7. Neuropsychiatry Outlook in India

8. India Neuropsychiatry Market Outlook

  • 8.1. India Neuropsychiatry -Treatment Devices Market Size & Forecast
    • 8.1.1.By Value (Historic 2010-14)
    • 8.1.2. By Value (Forecast 2015E-2020F)
    • 8.1.3. By Drugs, By Value, By Percentage (Estimated 2015E)
    • 8.1.4. By Drugs, By Value, By Percentage (Forecast 2020F)
  • 8.2. India Neuropsychiatry - Total Devices Market Size & Forecast
    • 8.2.1. By Value (Historic 2010-14)
    • 8.2.2. By Value (Forecast 2015E-2020F)
    • 8.2.3. By Region (Estimated 2015E)
    • 8.2.4. By Region (Forecast 2020F)
  • 8.3. India Neuropsychiatry -Treatment Devices Market Size & Forecast
    • 8.3.1. By Value (Estimated 2015E)
    • 8.3.2. By Value (Forecast 2020F)
  • 8.4. India Neuropsychiatry -Treatment Devices Market Size & Forecast
    • 8.4.1. By Value (Estimated 2015E)
    • 8.4.2. By Value (Forecast 2020F)
  • 8.5. India Neuropsychiatry Market-Drugs Market Size & Forecast
    • 8.5.1. By Value (Historic 2010-14)
    • 8.5.2. By Value (Forecast 2015E-2020F)
    • 8.5.3. By Region (Estimated 2015E)
    • 8.5.4. By Region (Forecast 2020F)

9. India Neuropsychiatry Market-Policy and Regulatory Landscape

10. India Neuropsychiatry Market- Dynamics

  • 10.1. Drivers
  • 10.2. Challenges

11. India Neuropsychiatry Industry-Trends & Developments

12. India Economic Profile

13. Neuropsychiatry Industry SWOT Analysis

14. Market Entry Strategies for Foreign Companies

15. India Neuropsychiatry Drug Market Analysis, By Major Drug Manufacturers

16. Competitive Landscape

17. Company Profiling

  • 17.1. Sun Pharmaceutical Industries Ltd.
  • 17.2. Torrent Pharma
  • 17.3. GlaxoSmithKline Pharmaceuticals Ltd.
  • 17.4. Cipla
  • 17.5. Abbott Limited
  • 17.6. Biocon Limited
  • 17.7. Glenmark Pharmaceuticals
  • 17.8. Alembic Ltd.
  • 17.9. Nicholas Primal
  • 17.10. Aventis Pharma Limited

18. Strategic Recommendations

List of Figures

  • Figure 1: Neuropsychiatry Devices and their Classification
  • Figure 2: Indian Neuropsychiatry Devices Industry Structure
  • Figure 3: India Healthcare Market, By Type of service offered and sector, 2014
  • Figure 4: India Health Care Delivery System
  • Figure 5: India Drug Industry Value Chain, By Type of service offered and sector, 2014
  • Figure 6: Neuropsychiatric Market Value in India, 2010-2014 (in USD Billion)
  • Figure 7: Healthcare Expenditure Total Percentage of GDP in India (in %)
  • Figure 8: Per Capita Healthcare Expenditure in India (in USD)
  • Figure 9: Urban Population in India (in %)
  • Figure 10: Neuropsychiatric Market Value in India, 2015E-2020F (in USD Billion/INR)
  • Figure 11: Neuropsychiatric Market Value in India, By Drug and Devices, By Percentage, 2015E
  • Figure 12: Neuropsychiatric Market Value in India, By Drug and Devices, By Percentage, 2020F
  • Figure 13: Total Neuropsychiatric Devices Market Value in India, 2010-2014 (in USD Million/INR Thousand Crore)
  • Figure 14: Total Neuropsychiatric Devices Market Value in India, 2015E-2020F (in USD Million/INR Thousand Crore)
  • Figure 15: Neuropsychiatric Devices Market Value in India, By Region, 2015E
  • Figure 16: Neuropsychiatric Devices Market Value in India, By, Region 2020F
  • Figure 17: Neuropsychiatric Device Market Value in India, By Diagnostics and Treatment - 2015E
  • Figure 18: Neuropsychiatric Device Market Value in India, By Diagnostics and Treatment- 2020F
  • Figure 19: India Neuropsychiatry Drug Market Size , By Value, 2010-2014(USD Billion/INR Thousand Crore)
  • Figure 20: India Neuropsychiatry Drug Market Size , By Value, 2015E-2020F(USD Billion/INR Thousand Crore)
  • Figure 21: Neuropsychiatric Drugs Market Value in India, By Region 2015E
  • Figure 22: Neuropsychiatric Drugs Market Value in India, By Region 2020F
  • Figure 23: Sales Comparison of Large Size Neuropsychiatric Market Players, 2011-2015 (INR Crores)
  • Figure 24: EBITDA Comparison of Large Size Neuropsychiatric Market Players, 2011-2015 (INR Crores)
  • Figure 25: EBIT Comparison of Large Size Neuropsychiatric Market Players, 2011-2015 (INR Crores)
  • Figure 26: PBT Comparison of Large Size Neuropsychiatric Market Players, 2011-2015 (INR Crores)
  • Figure 27: PAT Comparison of Large Size Neuropsychiatric Market Players, 2011-2015 (INR Crores)
  • Figure 28: Current Ratio Comparison of Large Size Neuropsychiatric Market Players, 2011-2015 (INR Crores)
  • Figure 29: Gross Profit Ratio Comparison of Large Size Neuropsychiatric Market Players, 2011-2015 (INR Crores)
  • Figure 30: Debt Equity Ratio Comparison of Large Size Neuropsychiatric Market Players , 2011-2015 (INR Crores)
  • Figure 31: Sales Comparison of Medium Size Companies, 2011-2015 (INR Crores)
  • Figure 32: EBITDA Comparison of Medium Size Companies, 2011-2015 (INR Crores)
  • Figure 33: EBIT Comparison of Medium Size Companies, 2011-2015 (INR Crores)
  • Figure 34: PBT Comparison of Medium Size Companies, 2011-2015 (INR Crores)
  • Figure 35: PAT Comparison of Medium Size Companies, 2011-2015 (INR Crores)
  • Figure 36: Current Ratio Comparison of Medium Size Companies, 2011-2015 (INR Crores)
  • Figure 37: Gross Profit Ratio Comparison of Medium Size Companies, 2011-2015 (INR Crores)
  • Figure 38: Debt Equity Ratio Comparison of Medium Size Companies, 2011-2015 (INR Crores)
  • Figure 39: Alembic Ltd. Percentage Revenue, By Business Segment (2014 E)
  • Figure 40: Nicholas Piramal Percentage Revenue, By Business Segment (2015)
  • Figure 41: Nicholas Piramal Percentage Revenue, By Geography (2015)

List of Tables

  • Table 1: Mental Patients Statistics in India, 2012
  • Table 2: Patients admitted to the Long term Mental Medical care in India, 2012
  • Table 3: Number of Patients with Mental Disorders, By state, 2013
Back to Top